Previous Article | Next Article ![]()
Journal of Clinical Microbiology, June 1998, p. 1534-1538, Vol. 36, No. 6
Laboratory of Virology and AIDS Center,
Received 22 December 1997/Returned for modification 25 February
1998/Accepted 17 March 1998
A total of 234 pools were prepared from 10,692 consecutive serum
samples negative for antibodies to human immunodeficiency virus type 1 (HIV-1) and HIV-2 collected at five virological laboratories (average
pool size, 45 serum samples). Pools were screened for the presence of
HIV-1 RNA by a modified commercial assay (Amplicor HIV-1 Monitor test)
which included an additional polyethylene glycol (PEG) precipitation
step prior to purification of viral RNA (PEG Amplicor assay). The
sensitivity of this assay for HIV-1 RNA detection in individual serum
samples within pools matches that of standard commercial assays for
individual serum samples, i.e., 500 HIV-1 RNA copies per ml. Five pools
were identified as positive, and each one contained one
antibody-negative, HIV-1 RNA-positive serum sample, corresponding to an
average of 1 infected sample per 2,138 serum samples. Retrospective
analysis revealed that the five HIV-1 RNA-positive specimens originated
from individuals who had symptomatic primary HIV-1 infection at the
time of sample collection and who were also positive for p24
antigenemia. We next assessed the possibility of performing the
prepurification step by high-speed centrifugation (50,000 × g for 80 min) of 1.5-ml pools containing 25 µl of 60 individual serum samples, of which only 1 contained HIV-1 RNA
(centrifugation Amplicor assay). The sensitivity of this assay also
matches the sensitivities of standard commercial assays for HIV-1 RNA
detection in individual serum samples. The results demonstrate that
both assays with pooled sera can be applied to the screening of large
numbers of serum samples in a time- and cost-efficient manner.
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Detection of Human Immunodeficiency Virus Type 1 (HIV-1) RNA in
Pools of Sera Negative for Antibodies to HIV-1 and HIV-2
*
Corresponding author. Mailing address: Laboratory of
Virology and AIDS Center, Division of Infectious Diseases, Geneva
University Hospital, 1211 Geneva 14, Switzerland. Phone:
41.22/37.24.991. Fax: 41.22/37.24.990. E-mail:
luc.perrin{at}hcuge.ch.
Journal of Clinical Microbiology, June 1998, p. 1534-1538, Vol. 36, No. 6
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|